Winrevair 45 mg

Winrevair 45 mg is a medicine authorised by Swissmedic under authorisation number 69787. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 October 2024 and the authorisation is limited until 15 October 2029. ATC code C02KX places the medicine in the group Antihypertensives.

  • Dispensing category B
  • Authorisation number 69787
  • ATC C02KX
  • Biotechnological medicines
Authorisation data
Authorisation number69787
NameWinrevair 45 mg
Full nameWinrevair 45 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holderMSD Merck Sharp & Dohme AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeC02KX
First authorisation16 October 2024
Authorisation validity15 October 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Winrevair 45 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB16 October 2024
2Winrevair 60 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB16 October 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11SetC02KX02.07.1.B
22SetC02KX02.07.1.B
31SetC02KX02.07.1.B
42SetC02KX02.07.1.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Winrevair 45 mg authorised in Switzerland?

Yes. Winrevair 45 mg is authorised by Swissmedic under authorisation number 69787, data as of 01 September 2026. The authorisation is limited until 15 October 2029.

Which dispensing category does Winrevair 45 mg have?

Winrevair 45 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Winrevair 45 mg?

The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com